187 related articles for article (PubMed ID: 21532361)
1. Efficacy, safety, and tolerability of sertraline on depressive symptoms in women with comorbid migraine: an open-label study.
MacGregor EA; Frith AA; Hackshaw A
J Clin Psychopharmacol; 2011 Jun; 31(3):392-3. PubMed ID: 21532361
[No Abstract] [Full Text] [Related]
2. Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline. A case report.
Bickel A; Kornhuber J; Maihöfner C; Ropohl A
Pharmacopsychiatry; 2005 Nov; 38(6):327-8. PubMed ID: 16342007
[TBL] [Abstract][Full Text] [Related]
3. Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report.
Boutilier AS; Gardner DM
J Clin Pharm Ther; 2003 Feb; 28(1):69-72. PubMed ID: 12605621
[No Abstract] [Full Text] [Related]
4. Selective serotonin reuptake inhibitors for migraine prophylaxis.
Landy S; McGinnis J; Curlin D; Laizure SC
Headache; 1999 Jan; 39(1):28-32. PubMed ID: 15613191
[TBL] [Abstract][Full Text] [Related]
5. [Not Available].
Diener H-
MMW Fortschr Med; 2017 Oct; 159(18):32. PubMed ID: 29071625
[No Abstract] [Full Text] [Related]
6. Eletriptan review.
Färkkilä M; Kallela M
Expert Opin Pharmacother; 2005 Apr; 6(4):625-30. PubMed ID: 15934888
[TBL] [Abstract][Full Text] [Related]
7. Sertraline for the Treatment of Depression in Vascular Cognitive Impairment.
Weissberger GH; Yarns BC; Chen ST; Narvaez T; Bussel N; Sultzer DL
Am J Geriatr Psychiatry; 2018 Aug; 26(8):908-909. PubMed ID: 29779907
[No Abstract] [Full Text] [Related]
8. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
[TBL] [Abstract][Full Text] [Related]
9. [Lung infiltrates associated with sertraline administration].
Salcedo Mingoarranz AL; Puebla Villaescusa A; De Agustín Sierra L; Ramírez Cruz S; Hidalgo Correas FJ; García Díaz B
Farm Hosp; 2016 Nov; 40(n06):624-626. PubMed ID: 27894233
[No Abstract] [Full Text] [Related]
10. Almotriptan efficacy in migraine with developing allodynia is as high as the efficacy in migraine without allodynia--but is it the same in migraine with established allodynia?
Burstein R
Headache; 2009 Mar; 49(3):364-5. PubMed ID: 19267784
[No Abstract] [Full Text] [Related]
11. Spotlight on eletriptan in migraine.
McCormack PL; Keating GM
CNS Drugs; 2006; 20(11):961-4. PubMed ID: 17044732
[TBL] [Abstract][Full Text] [Related]
12. Real-life experiences in migraine therapy.
Turcani P; Farkasova D; Marcek T; Turcani M
Bratisl Lek Listy; 2010; 111(2):74-8. PubMed ID: 20429318
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
Sir A; D'Souza RF; Uguz S; George T; Vahip S; Hopwood M; Martin AJ; Lam W; Burt T
J Clin Psychiatry; 2005 Oct; 66(10):1312-20. PubMed ID: 16259546
[TBL] [Abstract][Full Text] [Related]
14. Self-Harm in Sertraline-Induced Akathisia.
Nepal H; Black E; Bhattarai M
Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 28006090
[No Abstract] [Full Text] [Related]
15. Eletriptan: a review of its use in the acute treatment of migraine.
McCormack PL; Keating GM
Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
[TBL] [Abstract][Full Text] [Related]
16. Comparative sensitivity of stopwatch methodology and conventional pain assessment measures for detecting early response to triptans in migraine: results of a randomized, open-label pilot study.
Sunshine A; Mulhern SA; Olson N; Elkind A; Almas M; Sikes C
Clin Ther; 2006 Aug; 28(8):1107-1115. PubMed ID: 16982287
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of fluoxetine and sumatriptan: the Canadian experience.
Joffe RT; Sokolov ST
Acta Psychiatr Scand; 1997 Jun; 95(6):551-2. PubMed ID: 9242852
[TBL] [Abstract][Full Text] [Related]
18. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
[TBL] [Abstract][Full Text] [Related]
19. Sumatriptan versus eletriptan: which is best?
Dodick DW
Lancet Neurol; 2002 Dec; 1(8):474. PubMed ID: 12849329
[No Abstract] [Full Text] [Related]
20. Safety and efficacy of eletriptan in the treatment of acute migraine.
Takiya L; Piccininni LC; Kamath V
Pharmacotherapy; 2006 Jan; 26(1):115-28. PubMed ID: 16506353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
